{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-031574","form_type":"8-K","ticker":"AMS","cik":"0000744825","company_name":"AMERICAN SHARED HOSPITAL SERVICES","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.931728+00:00","generated_at":"2026-06-08T05:53:46.385329+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"American Shared Hospital Services Q3 revenue up 6.3% to $5.1M; net income falls to $0.02/sh","bullets":["Revenue $5.134M (+6.3% YoY); gross margin 40.9% vs 40.5%.","Net income $118k ($0.02 diluted) vs $316k ($0.05) in Q3 2022; operating income $90k vs $448k.","Adjusted EBITDA $1.669M vs $1.966M; selling/admin costs up 37.7% to $1.735M on new business investment.","Cash $14.655M at Sept 30, up from $12.453M at Dec 31; equity $3.53/sh.","Two new Gamma Knife Esprit upgrade orders from existing customers; international centers advancing (Ecuador restart, Mexico LINAC Q1 2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-031574","json":"https://secwatch.observer/filing/0001437749-23-031574.json","markdown":"https://secwatch.observer/filing/0001437749-23-031574.md","text":"https://secwatch.observer/filing/0001437749-23-031574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/0001437749-23-031574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/asha20231107_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:53:46.385329+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f678157d6ad229c2a3c361128cf226d7ab69c24","claim":"AMERICAN SHARED HOSPITAL SERVICES reported the third quarter ended September 30, 2023 results: revenue $5,134,000, net income $118,000, EPS $0.02 per diluted share.","evidence_excerpt":"systems and services, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights ● Total revenue in the third quarter was $5,134,000, an increase of 6.3% from the comparable period in 2022. Total proton therapy revenue decreased 5.9% period-over-period; fractions decreased 12.8%. Gamma Knife revenue increased","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/0001437749-23-031574-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$5,134,000"},{"label":"Net income","value":"$118,000"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}